AMGN Amgen Inc
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official
Market Value*
$150.10B
Revenue (FY)
$36.75B 2025-12-31
Net Income (FY)
$7.71B
P/E (float-based)
19.5
American multinational biopharmaceutical company.
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official
American multinational biopharmaceutical company.